⌘K

Login Start Free

Home/Filings/4/0001209191-23-021708

4//SEC Filing

JOHNSON JAMES A 4

Accession 0001209191-23-021708

CIK 0001620463other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 6:59 PM ET

Size

4.6 KB

Accession

0001209191-23-021708

Insider Transaction Report

Form 4

Period: 2023-03-29

Athira Pharma, Inc.ATHA

JOHNSON JAMES A

Director

Transactions

Purchase
Common Stock
2023-03-29$2.40/sh+5,000$12,000→ 5,000 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Athira Pharma, Inc.

CIK 0001620463

Entity typeother

Related Parties

1

filerCIK 0001225501

Filing Metadata

Form type: 4
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 6:59 PM ET
Size: 4.6 KB

View on SEC.gov